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Abstract
Background: Compelling evidence from large randomized trials demonstrates the salutary effects of ischemic
postconditioning on cardioprotection against ischemic/reperfusion injury. However, some studies appear negative
findings.
This study was designed to assess the short-and long-term effects of postconditioning (Poc) in studies including
evolving ST-elevation myocardial infarction (STEMI).
Methods: Relevant studies were identified through an electronic literature search from the PubMed, Library of
Congress, Embase, Cochrane Central Register of Controlled Trials, and ISI Web of Science. Studies published up to
December 2014 were eligible for inclusion. Patients older than 18 years presenting within 12 h of the first STEMI
and eligible for angioplasty were considered for the study.
Results: The 25 trials allocated 1136 patients to perform locational postconditioning cycles at the onset of
reperfusion and 1153 patients to usual percutaneous coronary intervention (PCI). Ischemic postconditioning
demonstrated a decrease in serum cardiac enzymes creatine kinase (CK) and CK-MB (P < 0.00001 and P =0.25,
respectively) in the subgroup analysis based on direct stenting. Reduction in infarct size by imaging was showed
during7 days after myocardial infarction (P =0.01), but not in the longterm (P = 0.08). The wall motion score index
was improved in both the short term within 7 days (P = 0.009) and the long term over 6 months after receiving Poc
(P = 0.02). All included studies were limited by the high risk of performance and publication bias.
Conclusions: Ischemic postconditioning by brief interruptions of coronary blood flow at the onset of reperfusion
after PCI appears to be superior to PCI alone in reducing myocardial injury and improving left ventricular function,
especially in patients who have received direct stenting in PCI.
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Background
Ischemic/reperfusion injury appearing after primary per-
cutaneous coronary intervention (PCI) abrogates myo-
cardial salvage and may increase infarct size [1]. It was
proved that ischemic preconditioning, which involved a
series of brief ischemia/reperfusion cycles and performed
before ischemia, was explicitly a cardioprotective
strategy [2–4]. Unlike preconditioning, ischemic post-
conditioning, which involves brief episodes of ischemia/
reperfusion during early reperfusion, has been demon-
strated to be effective in many studies [5–9]. Ischemic
postconditioning has a promising potential to be applied
in the clinic. However, some studies suggest that ische-
mic postconditioning during primary PCI does not re-
duce infarct size or improve myocardial function
recovery [10, 11]. The purpose of this paper was to fur-
ther summarize the evidence supporting cardioprotec-
tion of ischemic postconditioning in patients with acute
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To avoid insufficient number of studies, an electronic lit-
erature search was simultaneously conducted across the
PubMed, Library of Congress, Embase, Cochrane Cen-
tral Register of Controlled Trials, and ISI Web of Sci-
ence. Two independent evaluators reviewed all English
language articles published up to 2014. The following
key words were used as search terms: ischemic postcon-
ditioning, reperfusion, ischemic reperfusion injury, pri-
mary percutaneous intervention, controlled trials, and
randomized controlled trials (RCTs). All prospective,
randomized, single-center, or multicenter clinical trials
were included.
Eligibility criteria
Criteria for inclusion were as follows:(1) subjects with
explicit STEMI, (2) two reperfusion strategies, PCI with
postconditioning (Poc) or conventional (Con) PCI, were
compared, (3) a similar baseline between Poc and the
control group, with a good match of age, gender, ische-
mic time, and risk factors, (4) one or more myocardial
injury–related indicators, which involve peak creatine
kinase (CK), peak CK-MB, ST-segment resolution, in-
farct size (IS), left ventricular ejection fraction (LVEF),
and wall motion score index (WMSI). Continuous vari-
ables were reported as mean ± standard deviation (SD).
Only the latest study was included in the meta-analysis
for identical or largely similar articles.
Study selection and quality assessment
Two investigators independently assessed the eligibility
of identified studies. The studies that were evaluated
were RCTs that focused on the role of Poc in STEMI.
Published abstracts or without data were excluded. Dis-
agreement resolved by discussion or by referral to a
third assess or if necessary. Complete consensus among
the authors on the final results was achieved. Studies in-
cluded in the meta-analysis had to fulfill the aforemen-
tioned eligibility criteria. The criteria for study quality
outlined by the Cochrane Reviewer’s Handbook 4.2were
adopted for quality assessment of included RCTs. These
criteria were as follows: (1) correct random methods, (2)
randomization, (3) blindness assessment, (4) complete-
ness of the follow-up and using ITT (intention-to-treat)
analysis to deal with the dropouts.
Statistical analysis
Continuous data were reported either as mean (SD) or
median (interquartile range). For continuous data, mean
difference was calculated where same scale was used to
measure relevant outcomes (peak CK, peak CK-MB, LV
EF, and WMSI). A random effects model was used to
pool data, and the corresponding forest plots were
constructed. The Cochran’s Q test was used to assess
the heterogeneity among studies and was complemented
by the I2 statistic [12]. All analyses were conducted using
the statistical software Review Manager (RevMan) ver-
sion 5.3. The authors are solely responsible for the de-
sign and conduct of this study and its final contents.
Results
Identification of studies
A total of 25 eligible publications were screened by
the investigators. The studies that were excluded were
as follows: (1) 949 manuscripts based on titles and
abstracts and (2) 27 articles that either lacked original
data [5, 13, 14], or were with inaccurate data [15], or
involved remote postconditioning [16–18] and
pharmacological postconditioning [19–24], or involved
patients who were not suffering from STEMI and
treated with PCI [6, 25–37]. The studies were ex-
cluded based on the full-text review. Twenty-five
studies [7–11, 38–57] were included in this meta-
analysis (Fig. 1).
Study characteristics
Among the 2289 participants included in the meta-
analysis, 1136 patients were in the postconditioning
group and 1153 in the conventional care group. Charac-
teristics of studies and patients are summarized in
Tables 1 and 2.
The Poc protocol (cycles × ischemia/reperfusion in
seconds) varied between studies, being 2 × 90″/180″ in
1 study, 10 × 30″/30″ in 1 study, 3 × 30″/30″ to 4 ×
30″/30″ in 9 studies, and 3 × 60″/60″ to 4 × 60″/60″ in
14 studies. The follow-up in the trials varied from 3 days
to 3.4 years. The relevant outcomes in all studies include
markers of cardiac injury and left ventricular function
(Table 2).
Fig. 1 Flow diagram for the selection of articles
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PCI was performed by direct stenting in some studies
[7–9, 11, 38–42, 47–49, 52, 56]. However, in other stud-
ies [10, 43–46, 50, 51, 53, 55, 57], the choice of stent
was left to the discretion of the operator. Balloon angio-
plasty or thrombus aspiration was also allowed if a stent
could not be deployed or was considered harmful.
In the eligible studies, troponin levels were measured
in eight studies [10, 11, 41, 44, 45, 49, 52, 56]. Eighteen
[7, 9, 10, 38–42, 45–49, 51, 53, 54, 56, 57] studies con-
tained data on peak or the area under the curve of CK
or CK-MB. IS was measured by single-photon emission
computed tomography (SPECT) or cardiovascular mag-
netic resonance (CMR) in eleven studies [7, 8, 10, 11, 41,
44, 46, 49, 51, 52, 57]. Global left ventricular function as
determined by LVEF was measured in nine studies by
echocardiography [7, 41, 42, 46, 47, 49–52], in eight
studies by CMR [8, 11, 44, 45, 51, 54, 55, 57], and in one
study by both echocardiography and CMR [10]. Regional
left ventricular function was measured by WMSI in six
studies [9, 39, 42, 46, 48, 50].
Study quality
The analysis of the study quality in the 25 eligible stud-
ies is presented in Table 3. Baselines between the Poc
group and the control group in all the studies were com-
parable. The measurement data was compared by the
Student t test, and count data was compared by χ2 test
between the two groups. In terms of quality, each of
these studies would be graded level B according to the
Cochrane Reviewer’s Handbook 4.2 for quality assess-
ment of included RCTs.
Biomarkers of acute myocardial injury
The commonly measured myocardial injury biochemical
markers of acute myocardialinfarction (AMI) are CK
Table 1 Characteristics of studies included in the meta-analysis














Staat [38] France 2005 16/14 75/93 58/56 80/50 20/13 57/56 38/36
Ma [9] China 2006 47/47 66/71 64/64 NR 38/45 NR 62/55
Ma [39] China 2007 32/29 66/70 64/64 NR 38/45 NR 59/55
Yang [7] China 2007 23/18 87/61 59/63 61/56 26/28 61/50 70/61
Laskey [40] USA 2008 12/12 58/58 60/58 58/75 42/42 NR 75/83
Thibault [41] France 2008 17/21 76/78 56/56 52/49 10/12 65/65 29/35
Lin1 [42]a China 2010 25/26 84/65 59/63 56/42 24/27 56/50 52/54
Lin2 [42]a China 2010 24/26 71/65 58/63 67/42 21/27 67/50 58/54
Lonborg [43, 44]b Denmark 2010 59/59 69/74 61/62 46/41 7/7 61/49 37/32
Sorensson [45] Sweden 2010 38/38 82/89 63/62 77/62 NR 26/29 16/29
Xue [46] China 2010 23/20 95/94 54/62 16/24 21/29 63/71 37/71
Garcia [47] USA 2011 22/21 86/76 61/55 73/71 5/19 23/43 73/71
Liu [48] China 2011 30/34 73/68 59/59 NR 30/32 57/61 37/39
Freixa [10] Spain 2012 39/40 84/72 59/60 44/35 23/17 51/62 49/50
Tarantini [49] Italy 2012 37/38 85/85 60/60 51/49 18/3 67/77 59/49
Thuny [8] France 2102 25/25 76/72 57/57 36/48 20/14 68/64 40/48
Zhao [50] China 2012 30/32 97/87 57/62 31/17 13/27 69/77 50/67
Dwyer [51] Canada 2013 50/52 88/89 57/57 36/29 6/14 44/44 42/33
Elzbieciak [52] Poland 2013 18/21 67/86 60/58 61/86 22/24 67/52 78/91
Hahn [53] Korea 2013 350/350 79/75 60/60 40/46 24/25 53/52 46/46
Mewton [54] France 2013 25/25 76/72 57/57 NR 20/14 68/64 48/40
Sorensson [55] Sweden 2013 33/35 85/89 63/62 NR 29/32 27/26 15/31
Dong [56] China 2014 32/30 63/73 70/68 NR 34/37 41/50 72/63
Limalanathan [11] Norway 2014 120/129 84/80 61/60 NR 4/2 49/54 29/25
Waltenberger [57] Germany 2014 25/27 68/70 60/60 12/11 12/7 60/55 48/33
aLonborg et al. published 2 articles on the same trial
bLin et al. compared 60-s postconditioning with 30-s postconditioning and no postconditioning (routine) in this study
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Table 2 Characteristics of studies included in the meta-analysis
Author Country Year Chest
pain
Elapsed time (m) Culprit lesion Protocal Endpoint Follow-up
Staat France 2005 ≤12 h NR LAD (38/43); RCA (62/57) 60″/60″ × 4 CKAUC;peak CK; blush grade; STR 3d
Ma China 2006 ≤12 h 395 ± 150/426 ± 150 LAD (49/53); LCX (23/17); RCA (28/30) 30″/30″ × 3 peak CK;peak CK-MB; WMSI 7d;2 m
Ma China 2007 ≤12 h NR LAD (53/52); LCX (22/17); RCA (25/31) 30″/30″ × 3 peak CK;peak CK-MB; WMSI 7d;2 m
Yang China 2007 NR 312 ± 48/264 ± 42 LAD (65/61); LCX (9/6); RCA (26/33) 30″/30″ × 3 peakCK; CKAUC;IS; LVEF 3d;1w
Laskey USA 2008 ≤6 h 228 ± 43/222 ± 54 LAD (100/100); LCX (0); RCA (0) 90″/180″ × 2 peak CK; STR NR
Thibault France 2008 ≤6 h 283 ± 82/297 ± 104 NR 60″/60″ × 4 CKAUC; TnI;IS; LVEF 6 m;12 m
Lin China 2010 ≤12 h NR LAD (64/62); LCX (8/8); RCA (28/30) 30″/30″ × 3 TNFα; LV EF (7d、1y); WMSI 7d;1y
Lin China 2010 ≤12 h NR LAD (54/62); LCX (8/77); RCA (38/31) 60″/60″ × 3 TNFα;LV EF (7d、1y); WMSI 7d;1y
Lonborg Denmark 2010 ≤12 h 241 ± 148.9/255 ± 196 LAD (44/39); LCX (8/19); RCA (47/42) 30″/30″ × 4 IS;IS/AAR;LVEF;peak TnT 3 m
Sorensson Sweden 2010 ≤6 h 165 ± 63.7/185 ± 87.41 LAD (37/37); LCX (11/3); RCA (53/61) 60″/60″ × 4 IS/AAR; TnTAUC; LVEF 6-9d
Xue China 2010 ≤12 h 4.1 ± 3.0/5.4 ± 3.7 LAD (42/59); LCX (0); RCA (58/41) 60″/60″ × 4 CK-MB, IS, LVEF, STR 7d
Garcia USA 2011 ≤12 h 4.5/4.4 LAD (36/24); LCX (23/10); RCA (41/67) 30″/30″ × 4 peakCK; CK-MB;LVEF 3.4y
Liu China 2011 ≤12 h 312 ± 102/324 ± 108 LAD (53/59); LCX (10/12); RCA (37/29) 30″/30″ × 3 peak CK; Peak CK-MB; WMSI;LVEF;
blush grade;IS
7d
Freixa Spain 2012 ≤12 h 326 ± 180/330 ± 211 LAD (51/39); LCX (NR) RCA (45/47) 60″/60″ × 4 peak CK; Peak CK-MB; TnT; STR;
IS (7d,6 m)
7d;6 m
Tarantini Italy 2012 ≤6 h 212 ± 85/194 ± 80 LAD (41/44); LCX (18/8); RCA (41/49) 60″/60″ × 4 peak TnI; LVEF;IS; 30d
Thuny France 2102 ≤12 h 289 ± 31/215 ± 20 LAD (56/56); LCX (0/8); RCA (44/36) 60″/60″ × 4 IS;peak CK 3d
Zhao China 2012 ≤12 h 309 ± 201/404 ± 191 LAD (53/53); LCX:NR; RCA:NR 60″/60″ × 4 LVEF; WMSI 1w;6 m
Dwyer Canada 2013 ≤6 h 150 ± 70/170 ± 84 LAD (50/46); LCX:(12/14); RCA:(38/40) 30″/30″ × 4 IS; AAR; PeakCK; LVEF 3d
Elzbieciak Poland 2013 ≤12 h 225.6 ± 139.4/317.6 ± 195.8 LAD (100/100); LCX (0) RCA (0) 60″/60″ × 4 IS; AAR; PeakCK-MB; peak TnT;
LVEF;IS/AAR
3d;6 m
Hahn Korea 2013 ≤12 h 196 ± 51/195 ± 171 LAD (47/45); LCX:(11/11); RCA:(42/44) 60″/60″ × 4 peakCK-MB; STR; blush grade 30d
Mewton France 2013 ≤12 h 289 ± 31 /215 ± 20 LAD (56/56); LCX (0/8); RCA (44/36) 60″/60″ × 4 LVEF;IS;IS/AAR 4d
Sorensson Sweden 2013 ≤6 h 165 ± 51/180 ± 84 LAD (33/37); LCX (9/3); RCA (57/60) 60″/60″ × 4 IS; LVEF 12 m
Dong China 2014 ≤12 h 300 ± 90/294 ± 66 LAD (56/43); LCX (6/10); RCA (38/47) 30″/30″ × 3 blush grade; STR; CK- MB; TnT; LVEF 7d;30d
Limalanathan Norway 2014 ≤6 h NR LAD (46/51); LCX (13/9); RCA (41/41) 60″/60″ × 4 IS (CECMR); STR; TnT; LVEF 2d;4 m
Waltenberger Germany 2014 ≤6 h NR LAD (28/26); LCX (NR); RCA (64/74) 30″/30″ × 10 CKAUC;IS; LVEF 4d;4 m;12 m
NR,not related; LAD,left anterior descending branch; RCA,right coronary arterry; LCX,left circumflex artery; CK,creatine kinase; CKAUC,CK area under the curve; CK-MB,creatine kinase isoenzyme; STR,ST resolution; WMSI,
















and CK-MB, which are associated with infarct size.
Compared with the Con group, the Poc group showed
no apparent decrease in the level of peak CK after AMI
[standard mean difference (SMD) = −0.49; 95 % confi-
dence interval (CI), −1.09 to−0.1; I2 = 91 %; P =0.11).
There was substantial between-study heterogeneity
(Cochran Q test, P < 0.00001, I2 = 91 %). Subgroup ana-
lysis based on the method of PCI (PCI was performed
only by direct stenting in some studies,and by other
methods including direct stenting,balloon dilatation,and
thrombus aspiration in rest of studies) showed that not
only the decrease in CK became more significant but the
heterogeneity also dropped with direct stenting (SMD =
−0.82; 95 % CI, −1.18 to−0.47;I2 = 64 %;P < 0.00001) as
compared with other methods (SMD = 0.96; 95 % CI,
−0.66 to 2.58;I2 = 96 %;P =0.25) (Fig. 2). The CK-MB re-
sult was similar to those of CK (Fig. 3). The funnel plots
with respect to the end point of CK and CK-MB showed
no significant publication bias (Fig. 4). Publication bias
measured by Egger’s test was not significant (P = 0.21, P
= 0.68, respectively). These results showed that Poc can
reduce ischemic necrosis of myocardium after acute in-
farction when patients received direct stenting.
Myocardial infarct size measured by imaging
The meta-analysis of the studies demonstrated that the
perfusion defect index on SPECT or CMR,an estimate of
infarct size during 72 h after AMI, significantly reduced
in the Poc group compared to the Con group. The
pooled outcome of studies suggested a reduction in IS as
measured by imaging (SMD = −0.82; 95 % CI, −1.44 to
−0.19; I2 = 91 %; P =0.01). There was substantial
between-study heterogeneity (Cochran Q test, P <
0.00001, I2 = 91 %) during 72 h after AMI. Subgroup
analysis based on direct stenting showed that the hetero-
geneity dropped with direct stenting (SMD = −0.6; 95 %
CI, −1.09 to−0.11;I2 = 75 %;P = 0.02) as compared with
other methods (SMD = −1.12; 95 % CI, −2.9 to 0.65;I2 =
96 %; P =0.22) (Fig. 5). However, no significant difference
was noted between the two groups more than
4 months after AMI (SMD = −0.43; 95 % CI, −0.9 to
−0.04; I2 = 87 %; P = 0.08), while there was a trend
Table 3 Quality assessments of studies included in the meta-analysis
Study Year Randomization Blinded assessment Dropout rate (%) Similar baseline
Staat 2005 yes no unclear yes
Ma 2006 yes no unclear yes
Ma 2007 yes no unclear yes
Yang 2007 yes unclear unclear yes
Laskey 2008 yes unclear 0 yes
Thibault 2008 yes single-blind 0 yes
Lin1 2010 yes no unclear yes
Lin2 2010 yes no unclear yes
Lonborg 2010 yes unclear 0.26 yes
Sorensson 2010 yes no 0.15 yes
Xue 2010 yes unclear 0 yes
Garcia 2011 yes unclear 0 yes
Liu 2011 yes unclear 0 yes
Freixa 2012 yes no 0 yes
Tarantini 2012 yes no 0.04 yes
Thuny 2102 yes no 0.19 yes
Zhao 2012 yes no 0.09 yes
Dwyer 2013 yes unclear 0.23 yes
Elzbieciak 2013 yes no 0 yes
Hahn 2013 yes no 0.04 yes
Mewton 2013 yes no 0 yes
Sorensson 2013 yes no 0 yes
Dong 2014 yes unclear 0 yes
Limalanathan 2014 yes no 0.08 yes
Waltenberger 2014 yes single-blind 0.13 yes
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toward the reduction of IS. Subgroup analysis based
on direct stenting showed that the heterogeneity
dropped with direct stenting (SMD = −0.16; 95 % CI,
−0.43 to−0.11; I2 = 16 %; P = 0.24) as compared with
other methods (SMD = −0.61; 95 % CI, −0.1.5 to 0.28;
I2 = 93 %; P =0.18) (Fig. 6). No significant change in
heterogeneity was noted when the studies were grouped
based on geographic region.
Cardiac function measures
LVEF was significantly improved in the Poc group in the
short term within 7 days after AMI (SMD= 0.41; 95 % CI,
Fig. 2 Effect of postconditioning on CK release during 72 h after PCI
Fig. 3 Effect of postconditioning on CK-MB release during 72 h after PCI
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0.16 to 0.65 I2 = 73 %; P = 0.001) (Fig. 7). LVEF also im-
proved in the Poc group than in the Con group over
4 months after AMI (SMD =0.48; 95 % CI, 0.11 to 0.85; P
=0.01). However, subgroup analysis showed that improve-
ment in LVEF was not significant. The heterogeneity
dropped with the involvement of direct stenting (SMD
=0.2; 95 % CI, −0.02 to 0.42; I2 = 0 %;P =0.07) as compared
with other methods (SMD= 0.57; 95 % CI, 0.02 to 1.13;I2
= 88 %;P =0.04) (Fig. 8). Patients receiving Poc had a lower
WMSI (a value of 1 is normal segmental motion and
higher values indicate poorer contraction) than those re-
ceiving usual primary PCI in both the short term within
7 days (SMD= −2.65; 95 % CI,−4.63 to−0.67; P = 0.009)
(Fig. 9) and the long term over 6 months (SMD= −3.48;
95 % CI,−6.47 to−0.5; P = 0.02) (Fig. 10).
Discussion
The current meta-analysis included data from 25 ran-
domized trials involving 2289 participants. The results
gave rise to a view that postconditioning following PCI
Fig. 4 Funnel plot for the analysis of acute myocardial injury biomarkers
Fig. 5 Effect of postconditioning on IS reduction during 7 days after PCI
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Fig. 6 Effect of postconditioning on IS 4–12months after myocardial infarction
Fig. 7 Effect of postconditioning on LV EF during 7 days after PCI
Gao et al. Lipids in Health and Disease  (2015) 14:147 Page 8 of 12
induced by transient coronary ischemia in STEMI pa-
tients may reduce myocardial injury biomarkers and im-
prove cardiac function, compared with the usual care
group. This cardioprotection was more apparent when
direct stenting was performed in PCI compared with
other methods of PCI, including balloon angioplasty and
thrombus aspiration. The lack of substantial effect of
Poc when PCI was completed by angioplasty or
thrombus aspiration was most likely due to inadequate
revascularization. However, despite the trend in IS re-
duction, no significant decrease was noted in IS over
4 months after AMI.
Reperfusion therapy is an effective therapeutic ap-
proach during the early stage of STEMI patients to pre-
vent heart failure and other cardiovascular events. Many
studies have verified that immediate reperfusion is crit-
ical to rescue the ischemic myocardium. However, reper-
fusion has the potential exacerbation of myocardium
injury, including myocardial stunning, no reflow, and
ventricular arrhythmias [58–60]. Therefore, attenuating
reperfusion injury has become an urgent challenge for
salvaging myocardium during reperfusion in STEMI pa-
tients. Poc performed during angioplasty is technically
simple and safe, for cycles of “ischemia/reperfusion” can
be easily achieved by repeatedly deflating and inflating
the balloon in the culprit artery. A number of studies
[7–9, 38–44, 46, 48, 50, 54, 56, 57] described salutary ef-
fects of Poc on ischemic/reperfusion injury. In contrast,
other studies [10, 11, 45, 47, 49, 51–53, 55] show nega-
tive effect of postconditioning, even harmful for myocar-
dium salvage. These studies present high heterogeneity
of result due to the difference of Poc protocol, measure-
ment, culprit artery, chest pain elapsed time, endpoints,
and the type of PCI. For example, IS can be measured
by SPECT or CMR, assessed by percentage of the area
at risk, a percentage of the left ventricular mass,or in
Fig. 8 Effect of postconditioning on LV EF 4 months after myocardial infarction
Fig. 9 Effect of postconditioning on WMSI during 7 days after myocardial infarction
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grams. A pooled analysis of RCTs has shown that in-
volvement of the left anterior descending (LAD) is one
of the strongest predictors of IS [61]. This study revealed
that postconditioning presents cardioprotection in pa-
tients with STEMI, especially in whom PCI was per-
formed by direct stenting. The reason may be that
reperfusion is more adequate by direct stenting than
other methods. Appropriate trials are needed to answer
this question. Eleven studies performed follow-up from
3 months to 3.4 year [10, 11, 41, 42, 44, 47, 50–52, 55, 57].
The short-term (within 7 days after PCI) beneficial effect
in the Poc group included reduced biomarkers of myocar-
dium injury, reduced IS measured by imaging,and the left
ventricular function assessed by LVEF or WMSI. Unfortu-
nately, the remarkable decrease of IS did not appear after
the long-term follow up. In both short- or long-term
follow-up, the global left ventricular function as deter-
mined by LVEF improved. Although the analysis suggest
that regional left ventricular function assessed by WMSI
showed positive result in both short- and long-term
follow-up,only several studies cover WMSI. Due to the
limited sample size, the results should not be considered
conclusive.
Poc could improve myocardial reperfusion in patients
with ST-elevation AMI undergoing PCI by reducing no
reflow. However, the mechanisms of Poc are not clear.
Previos study revealed that high concentrations of inor-
ganic phosphate, reactive oxygen species, and reactive
nitrogen species are all present during myocardial ische-
mia and during reperfusion [62]. Due to the importance
of oxidative stress and inflammation in atherosclerotic
plaques development and Cardiovascular disease pro-
gression, therapeutic of antioxidant seems to be very im-
portant [63]. So the cardioprotective effect of Poc partly
depend on antioxidant and anti-inflammatory.
Moreover, the question is whether different protocols
have different cardioprotective effects. Many different
protocols of postconditioning existed, such as 60 s ×
3circles, 60 s × 4circles, 30 s × 4circles, and so on, used
in available studies. However, only one study tested the
hypothesis that postconditioning of 60 s × 3 was more
protective than postconditioning of 30 s × 3 [42]. There-
fore, additional trials of a large scale are needed to
determine the optimal protocol. It is also reported that
ischemic postconditioning reduced infarct size in
normotensive but not hypertensive rat hearts [64, 65].
Experimental animal data suggest that the presence of
diabetes and related conditions, such as obesity and
metabolic syndrome, may affect the cardioprotective
efficacy of both ischemic and pharmacologic postcondi-
tioning. Przyklenk et al. [66] found that ischemic post-
conditioning cannot play a protective role in reducing
infarct size by isolated perfused heart of murine model
compared with the normoglycemic heart. In a retro-
spective analysis, postconditioning the human heart by
multiple balloon inflations failed to reduce irreversible
injury in patients above the age of 65 years [67]. Yellon
and colleagues demonstrated a decline in the effective-
ness of RISK pathway signaling with age [68]. They
suggested that cardioprotection associated with postcon-
ditioning may be affected by age, comorbidities, medica-
tions, and the method selection of PCI. Therefore,
future strategies will need to focus on the quality of re-
perfusion. Appropriate trial design is required to provide
clearer answers.
Limitations
Compared with previous studies, the analysis of the
present study involves a comprehensive literature search
including a large number of relevant studies. Postcondi-
tioning was associated with a reduction of infarct size as
determined by biochemical quantification and imaging.
Cardiac function was assessed by LVEF and WMSI. In
this meta-analysis, the long-term (over than 3 month)
effect of postconditioning was analyzed as well as the
short-term effect. Besides, method selection of PCI was
based on subgroup analysis. However, the limitations in-
herent to the studies contained in the analysis impact
the present-study results, such as small sample size, het-
erogeneity between studies, and risk of performance
bias.
Conclusion
Ischemic postconditioning during PCI in STEMI seems
to be superior to the conventional PCI alone in reducing
acute myocardial injury, infarction size, and left
Fig. 10 Effect of postconditioning on WMSI 6 months after myocardial infarction
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ventricular function including global and regional func-
tion, especially in patients who have received direct
stenting in PCI. Given the limitations of the current
available evidence, additional data involving potential
risk factors of restricting postconditioning from large
RCTs are needed.
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